Standard BioTools Inc.
LAB
$0.90
-$0.06-6.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.90M | -128.25M | -120.50M | -87.04M | -93.17M |
| Total Depreciation and Amortization | 15.05M | 22.26M | 20.21M | 16.22M | 17.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.48M | 24.82M | 24.61M | 16.89M | -3.30M |
| Change in Net Operating Assets | -44.98M | -6.03M | -17.19M | -18.27M | -25.17M |
| Cash from Operations | -74.34M | -87.21M | -92.88M | -111.26M | -143.45M |
| Capital Expenditure | -8.30M | -11.21M | -12.58M | -10.69M | -6.42M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -1.39M | -1.39M | -1.39M | 278.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.71M | 73.77M | 50.94M | 21.54M | 40.69M |
| Cash from Investing | 27.41M | 61.18M | 36.97M | 59.72M | 363.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -55.00M | -55.00M | -55.00M | -63.19M |
| Issuance of Common Stock | 1.05M | 833.00K | 901.00K | 593.00K | 665.00K |
| Repurchase of Common Stock | -484.00K | -403.00K | -361.00K | -161.00K | -11.18M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -545.00K |
| Cash from Financing | 570.00K | -54.57M | -54.46M | -82.93M | -102.62M |
| Foreign Exchange rate Adjustments | 842.00K | 675.00K | 470.00K | -318.00K | -696.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.52M | -79.93M | -109.90M | -134.87M | 116.32M |